$3.01
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+1,404.7% upside
Low Target
$33.37
Average Target
$45.29
High Target
$67.77
Current Price
$3.01
Current
$3.01
$3.01
Target
$45.29
$45.29
$33.37
$45.29 avg
$67.77
Scenario Analysis
Bear Case
$33.37
1,008.6%
Low target
Base Case
$45.29
+1,404.7%
Avg target
Bull Case
$67.77
+2,151.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$5.55
-45.8% from high
52-Week Low
$1.02
+195.9% from low
Target vs 52W High
$45.29
+716.0% vs high
Next Earnings Report
Aug 19, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.36
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |